Feedback / Questions
BMC128 - Evogene
https://www.prnewswire.com/news-releases/biomica-presents-positive-clinical-data-update-from-ongoing-phase-1-trial-of-microbiome-based-therapeutic-bmc128-for-refractory-rcc-nsclc--melanoma-302154259.html
May 23, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next